Warren Nelson
|
 |
The 1992 Ortho birth control Study intervie almost 7000 women, of whom 8% listed withdrawal and 4% listed the rhythm method. Effects of three combined oral contraceptive preparations containing desogestrel plus ethinyl estradiol on lipid metabolism in comparison common antibiotics online with two levonorgestrel preparations.The effects of three different desogestrel-containing combined oral contraceptive preparations on lipid metabolism were compared with those of two levonorgestrel contraceptives preparations. 48% of married women aged 15-44 had themselves been sterilized or had a sterilized partner in the Ortho survey. The differences seen between the desogestrel and levonorgestrel preparations can best be explained by the lower intrinsic androgenicity of 3-keto-desogestrel (active metabolite of desogestrel) than that of levonorgestrel. Birth control methods often disappoint the users and increasingly they turn to sterilization. The effects of these preparations were assessed on high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, apolipoprotein A-I, apolipoprotein B, the ratio of high-density lipoprotein cholesterol to low-density lipoprotein cholesterol, and the reach of apolipoprotein A-I to apolipoprotein B after 3 months of treatment, and the percentage changes with regard to pretreatment were calculated. Pelvic inflammatory disease is the reason. The monophasic desogestrel (150/30) and biphasic desogestrel preparations induced higher high-density lipoprotein cholesterol contraceptives and apolipoprotein A-I levels than did their levonorgestrel-containing counterparts. The failure rate is 6%. Diaphragms offer some protection against STDs, but their failure rate is 18%. Birth control over 30.Among 30-40 year old women, 40% of pregnancies are unplanned, which is indicative of the unreliability of the distinction control methods they are using. A 1992 study sho that 0.97% of women developed it within 20 days of use. A 1993 study follo 1253 implant users over 12 months and found a very low rate of pregnancy, ortho evra but 75% experienced some side effects during the first year. Depo-Provera is an injectable administered every 3 months, but after removal it can take up to a year for ovulation to return. Apolipoprotein B increased in all preparations. The antiatherogenic indexes (ratios of high-density lipoprotein cholesterol to low-density lipoprotein cholesterol and apolipoprotein A-I to apolipoprotein B were higher for monophasic desogestrel (150/30) and biphasic desogestrel than for comparable levonorgestrel-containing preparations. Norplant is a long-term implant containing Levonorgestrel with a failure rate of 0.5%. Side effects may include hair loss and weight gain; and links to breast cancer have also been suggested.. Taking the pill also helps prevent ovarian and endometrial cancer. Barrier methods also offer protection from sexually transmitted diseases including HIV. For women over the age of 30 who are healthy and do not smoke, low-Estrogen or no-Estrogen oral contraceptive pills are considered safe. Low-density lipoprotein cholesterol levels were increased in monophasic levonorgestrel and clearly decreased in the lowest ethinyl estradiol-containing monophasic desogestrel (150/20) and biphasic desogestrel preparations. Although reversal of tubal ligation succeeds in 43-88% of cases, conception cannot be guaranteed. Condoms are favored by 33% of unmarried women and 19% of married women. About half of the women using Norplant removed it after 2.5 years because of irregular bleeding. The following preparations were studied. Sexually active 40-44 year old unmarried women run a 14-19% risk of contracting a sexually transmitted disease (STD) in a 12-month period. (1) monophasic desogestrel (150/30), (2) monophasic desogestrel (150/20, containing 20 micrograms of ethinyl estradiol instead of 30 micrograms of ethinyl estradiol, (3) biphasic desogestrel, (4) monophasic levonorgestrel (150/30), and (5) triphasic levonorgestrel. IUDs are regaining popularity, but only 1% of women use them (ParaGard T380A or Progestasert). These two methods have failure rates of 24% and 19%, respectively.
|